nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.326	0.532	CbGbCtD
Rocuronium—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.187	0.305	CbGbCtD
Rocuronium—SLC22A1—Metformin—type 2 diabetes mellitus	0.1	0.163	CbGbCtD
Rocuronium—Electrocardiogram abnormal—Repaglinide—type 2 diabetes mellitus	0.00953	0.0377	CcSEcCtD
Rocuronium—Electrocardiogram abnormal—Pioglitazone—type 2 diabetes mellitus	0.00755	0.0299	CcSEcCtD
Rocuronium—Cardiovascular disorder—Repaglinide—type 2 diabetes mellitus	0.0071	0.0281	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Repaglinide—type 2 diabetes mellitus	0.00468	0.0185	CcSEcCtD
Rocuronium—Cardiovascular disorder—Orlistat—type 2 diabetes mellitus	0.00369	0.0146	CcSEcCtD
Rocuronium—Arrhythmia—Repaglinide—type 2 diabetes mellitus	0.0028	0.0111	CcSEcCtD
Rocuronium—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.00275	0.0109	CcSEcCtD
Rocuronium—Wheezing—Irbesartan—type 2 diabetes mellitus	0.00274	0.0108	CcSEcCtD
Rocuronium—Hypertension—Repaglinide—type 2 diabetes mellitus	0.00236	0.00932	CcSEcCtD
Rocuronium—Arrhythmia—Glipizide—type 2 diabetes mellitus	0.00232	0.00916	CcSEcCtD
Rocuronium—Asthma—Gliclazide—type 2 diabetes mellitus	0.00224	0.00885	CcSEcCtD
Rocuronium—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.00223	0.00881	CcSEcCtD
Rocuronium—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.00223	0.00881	CcSEcCtD
Rocuronium—Arrhythmia—Glimepiride—type 2 diabetes mellitus	0.00216	0.00855	CcSEcCtD
Rocuronium—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00216	0.00854	CcSEcCtD
Rocuronium—Rash—Miglitol—type 2 diabetes mellitus	0.00214	0.00847	CcSEcCtD
Rocuronium—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00214	0.00846	CcSEcCtD
Rocuronium—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.0021	0.00832	CcSEcCtD
Rocuronium—Muscular weakness—Valsartan—type 2 diabetes mellitus	0.0021	0.0083	CcSEcCtD
Rocuronium—Asthma—Orlistat—type 2 diabetes mellitus	0.00203	0.00804	CcSEcCtD
Rocuronium—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00202	0.00801	CcSEcCtD
Rocuronium—Nausea—Miglitol—type 2 diabetes mellitus	0.00202	0.00797	CcSEcCtD
Rocuronium—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.002	0.00791	CcSEcCtD
Rocuronium—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00197	0.00777	CcSEcCtD
Rocuronium—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00196	0.00777	CcSEcCtD
Rocuronium—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00196	0.00777	CcSEcCtD
Rocuronium—Arrhythmia—Bromocriptine—type 2 diabetes mellitus	0.00195	0.00771	CcSEcCtD
Rocuronium—Hypertension—Glipizide—type 2 diabetes mellitus	0.00195	0.00771	CcSEcCtD
Rocuronium—Rash—Tolbutamide—type 2 diabetes mellitus	0.00192	0.00761	CcSEcCtD
Rocuronium—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.0019	0.0075	CcSEcCtD
Rocuronium—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.00187	0.00738	CcSEcCtD
Rocuronium—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00182	0.0072	CcSEcCtD
Rocuronium—Hypertension—Glimepiride—type 2 diabetes mellitus	0.00182	0.00719	CcSEcCtD
Rocuronium—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00181	0.00717	CcSEcCtD
Rocuronium—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.00181	0.00717	CcSEcCtD
Rocuronium—Shock—Glipizide—type 2 diabetes mellitus	0.00181	0.00717	CcSEcCtD
Rocuronium—Muscular weakness—Irbesartan—type 2 diabetes mellitus	0.0018	0.00713	CcSEcCtD
Rocuronium—Asthma—Irbesartan—type 2 diabetes mellitus	0.00177	0.00699	CcSEcCtD
Rocuronium—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00177	0.00698	CcSEcCtD
Rocuronium—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.00176	0.00698	CcSEcCtD
Rocuronium—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00175	0.00693	CcSEcCtD
Rocuronium—Rash—Tolazamide—type 2 diabetes mellitus	0.00175	0.00693	CcSEcCtD
Rocuronium—Rash—Linagliptin—type 2 diabetes mellitus	0.00173	0.00685	CcSEcCtD
Rocuronium—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00173	0.00685	CcSEcCtD
Rocuronium—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00172	0.0068	CcSEcCtD
Rocuronium—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00171	0.00678	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.00171	0.00674	CcSEcCtD
Rocuronium—Muscular weakness—Losartan—type 2 diabetes mellitus	0.0017	0.00671	CcSEcCtD
Rocuronium—Vomiting—Acarbose—type 2 diabetes mellitus	0.0017	0.00671	CcSEcCtD
Rocuronium—Shock—Glimepiride—type 2 diabetes mellitus	0.00169	0.00669	CcSEcCtD
Rocuronium—Rash—Acarbose—type 2 diabetes mellitus	0.00168	0.00665	CcSEcCtD
Rocuronium—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00168	0.00665	CcSEcCtD
Rocuronium—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00168	0.00664	CcSEcCtD
Rocuronium—Nausea—Tolazamide—type 2 diabetes mellitus	0.00165	0.00652	CcSEcCtD
Rocuronium—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00165	0.00652	CcSEcCtD
Rocuronium—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.00164	0.00649	CcSEcCtD
Rocuronium—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00164	0.00649	CcSEcCtD
Rocuronium—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00164	0.00647	CcSEcCtD
Rocuronium—Rash—Nateglinide—type 2 diabetes mellitus	0.00162	0.00642	CcSEcCtD
Rocuronium—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00162	0.00641	CcSEcCtD
Rocuronium—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00161	0.00635	CcSEcCtD
Rocuronium—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.0016	0.00633	CcSEcCtD
Rocuronium—Nausea—Acarbose—type 2 diabetes mellitus	0.00158	0.00627	CcSEcCtD
Rocuronium—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00158	0.00623	CcSEcCtD
Rocuronium—Nausea—Nateglinide—type 2 diabetes mellitus	0.00153	0.00604	CcSEcCtD
Rocuronium—Shock—Bromocriptine—type 2 diabetes mellitus	0.00153	0.00604	CcSEcCtD
Rocuronium—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00151	0.00599	CcSEcCtD
Rocuronium—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00149	0.00589	CcSEcCtD
Rocuronium—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00145	0.00573	CcSEcCtD
Rocuronium—Asthma—Ramipril—type 2 diabetes mellitus	0.00143	0.00564	CcSEcCtD
Rocuronium—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00142	0.0056	CcSEcCtD
Rocuronium—Rash—Repaglinide—type 2 diabetes mellitus	0.0014	0.00555	CcSEcCtD
Rocuronium—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.0014	0.00555	CcSEcCtD
Rocuronium—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.0014	0.00555	CcSEcCtD
Rocuronium—Shock—Glyburide—type 2 diabetes mellitus	0.00139	0.00552	CcSEcCtD
Rocuronium—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00136	0.00537	CcSEcCtD
Rocuronium—Hypertension—Gliclazide—type 2 diabetes mellitus	0.00135	0.00533	CcSEcCtD
Rocuronium—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00133	0.00525	CcSEcCtD
Rocuronium—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00133	0.00524	CcSEcCtD
Rocuronium—Hypotension—Glyburide—type 2 diabetes mellitus	0.00132	0.00524	CcSEcCtD
Rocuronium—Nausea—Repaglinide—type 2 diabetes mellitus	0.00132	0.00523	CcSEcCtD
Rocuronium—Pruritus—Glipizide—type 2 diabetes mellitus	0.0013	0.00516	CcSEcCtD
Rocuronium—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.0013	0.00514	CcSEcCtD
Rocuronium—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00127	0.00501	CcSEcCtD
Rocuronium—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.00126	0.005	CcSEcCtD
Rocuronium—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00126	0.00499	CcSEcCtD
Rocuronium—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00125	0.00494	CcSEcCtD
Rocuronium—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00124	0.00491	CcSEcCtD
Rocuronium—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00122	0.00481	CcSEcCtD
Rocuronium—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00119	0.00471	CcSEcCtD
Rocuronium—Arrhythmia—Losartan—type 2 diabetes mellitus	0.00119	0.0047	CcSEcCtD
Rocuronium—Vomiting—Glipizide—type 2 diabetes mellitus	0.00117	0.00463	CcSEcCtD
Rocuronium—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00117	0.00463	CcSEcCtD
Rocuronium—Rash—Glipizide—type 2 diabetes mellitus	0.00116	0.00459	CcSEcCtD
Rocuronium—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00116	0.00459	CcSEcCtD
Rocuronium—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00116	0.00457	CcSEcCtD
Rocuronium—Shock—Valsartan—type 2 diabetes mellitus	0.00115	0.00455	CcSEcCtD
Rocuronium—Hypertension—Metformin—type 2 diabetes mellitus	0.00113	0.00446	CcSEcCtD
Rocuronium—Nausea—Glipizide—type 2 diabetes mellitus	0.00109	0.00433	CcSEcCtD
Rocuronium—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00109	0.00432	CcSEcCtD
Rocuronium—Hypotension—Valsartan—type 2 diabetes mellitus	0.00109	0.00432	CcSEcCtD
Rocuronium—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00109	0.00431	CcSEcCtD
Rocuronium—Rash—Glimepiride—type 2 diabetes mellitus	0.00108	0.00429	CcSEcCtD
Rocuronium—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00108	0.00428	CcSEcCtD
Rocuronium—Rash—Sitagliptin—type 2 diabetes mellitus	0.00108	0.00427	CcSEcCtD
Rocuronium—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00108	0.00427	CcSEcCtD
Rocuronium—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00106	0.00421	CcSEcCtD
Rocuronium—Shock—Metformin—type 2 diabetes mellitus	0.00105	0.00414	CcSEcCtD
Rocuronium—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00104	0.00413	CcSEcCtD
Rocuronium—Nausea—Glimepiride—type 2 diabetes mellitus	0.00102	0.00404	CcSEcCtD
Rocuronium—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.00102	0.00403	CcSEcCtD
Rocuronium—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00102	0.00403	CcSEcCtD
Rocuronium—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00101	0.00398	CcSEcCtD
Rocuronium—Pruritus—Glyburide—type 2 diabetes mellitus	0.001	0.00397	CcSEcCtD
Rocuronium—Hypotension—Metformin—type 2 diabetes mellitus	0.000995	0.00394	CcSEcCtD
Rocuronium—Shock—Irbesartan—type 2 diabetes mellitus	0.000989	0.00391	CcSEcCtD
Rocuronium—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000986	0.0039	CcSEcCtD
Rocuronium—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000981	0.00388	CcSEcCtD
Rocuronium—Rash—Bromocriptine—type 2 diabetes mellitus	0.000978	0.00387	CcSEcCtD
Rocuronium—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000977	0.00386	CcSEcCtD
Rocuronium—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000946	0.00374	CcSEcCtD
Rocuronium—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000939	0.00372	CcSEcCtD
Rocuronium—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000938	0.00371	CcSEcCtD
Rocuronium—Shock—Losartan—type 2 diabetes mellitus	0.000931	0.00368	CcSEcCtD
Rocuronium—Tachycardia—Losartan—type 2 diabetes mellitus	0.000923	0.00365	CcSEcCtD
Rocuronium—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000921	0.00364	CcSEcCtD
Rocuronium—Vomiting—Glyburide—type 2 diabetes mellitus	0.000902	0.00357	CcSEcCtD
Rocuronium—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000901	0.00356	CcSEcCtD
Rocuronium—Rash—Glyburide—type 2 diabetes mellitus	0.000894	0.00354	CcSEcCtD
Rocuronium—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000893	0.00353	CcSEcCtD
Rocuronium—Hypotension—Losartan—type 2 diabetes mellitus	0.000884	0.0035	CcSEcCtD
Rocuronium—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000862	0.00341	CcSEcCtD
Rocuronium—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000852	0.00337	CcSEcCtD
Rocuronium—Nausea—Glyburide—type 2 diabetes mellitus	0.000842	0.00333	CcSEcCtD
Rocuronium—Pruritus—Valsartan—type 2 diabetes mellitus	0.000828	0.00327	CcSEcCtD
Rocuronium—Pruritus—Orlistat—type 2 diabetes mellitus	0.000818	0.00323	CcSEcCtD
Rocuronium—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000811	0.00321	CcSEcCtD
Rocuronium—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000809	0.0032	CcSEcCtD
Rocuronium—Rash—Gliclazide—type 2 diabetes mellitus	0.000803	0.00317	CcSEcCtD
Rocuronium—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000802	0.00317	CcSEcCtD
Rocuronium—Shock—Ramipril—type 2 diabetes mellitus	0.000798	0.00316	CcSEcCtD
Rocuronium—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000792	0.00313	CcSEcCtD
Rocuronium—Hypotension—Ramipril—type 2 diabetes mellitus	0.000758	0.003	CcSEcCtD
Rocuronium—Nausea—Gliclazide—type 2 diabetes mellitus	0.000756	0.00299	CcSEcCtD
Rocuronium—Pruritus—Metformin—type 2 diabetes mellitus	0.000754	0.00298	CcSEcCtD
Rocuronium—Vomiting—Valsartan—type 2 diabetes mellitus	0.000744	0.00294	CcSEcCtD
Rocuronium—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000741	0.00293	CcSEcCtD
Rocuronium—Rash—Valsartan—type 2 diabetes mellitus	0.000738	0.00292	CcSEcCtD
Rocuronium—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000737	0.00291	CcSEcCtD
Rocuronium—Vomiting—Orlistat—type 2 diabetes mellitus	0.000735	0.00291	CcSEcCtD
Rocuronium—Rash—Orlistat—type 2 diabetes mellitus	0.000729	0.00288	CcSEcCtD
Rocuronium—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000728	0.00288	CcSEcCtD
Rocuronium—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000711	0.00281	CcSEcCtD
Rocuronium—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000697	0.00276	CcSEcCtD
Rocuronium—Nausea—Valsartan—type 2 diabetes mellitus	0.000695	0.00275	CcSEcCtD
Rocuronium—Nausea—Orlistat—type 2 diabetes mellitus	0.000687	0.00272	CcSEcCtD
Rocuronium—Vomiting—Metformin—type 2 diabetes mellitus	0.000677	0.00268	CcSEcCtD
Rocuronium—Rash—Metformin—type 2 diabetes mellitus	0.000672	0.00266	CcSEcCtD
Rocuronium—Dermatitis—Metformin—type 2 diabetes mellitus	0.000671	0.00265	CcSEcCtD
Rocuronium—Pruritus—Losartan—type 2 diabetes mellitus	0.000669	0.00265	CcSEcCtD
Rocuronium—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000639	0.00253	CcSEcCtD
Rocuronium—Rash—Irbesartan—type 2 diabetes mellitus	0.000634	0.00251	CcSEcCtD
Rocuronium—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000633	0.0025	CcSEcCtD
Rocuronium—Nausea—Metformin—type 2 diabetes mellitus	0.000633	0.0025	CcSEcCtD
Rocuronium—Vomiting—Losartan—type 2 diabetes mellitus	0.000601	0.00238	CcSEcCtD
Rocuronium—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000598	0.00236	CcSEcCtD
Rocuronium—Nausea—Irbesartan—type 2 diabetes mellitus	0.000597	0.00236	CcSEcCtD
Rocuronium—Rash—Losartan—type 2 diabetes mellitus	0.000596	0.00236	CcSEcCtD
Rocuronium—Dermatitis—Losartan—type 2 diabetes mellitus	0.000596	0.00236	CcSEcCtD
Rocuronium—Pruritus—Ramipril—type 2 diabetes mellitus	0.000574	0.00227	CcSEcCtD
Rocuronium—Nausea—Losartan—type 2 diabetes mellitus	0.000562	0.00222	CcSEcCtD
Rocuronium—Vomiting—Ramipril—type 2 diabetes mellitus	0.000516	0.00204	CcSEcCtD
Rocuronium—Rash—Ramipril—type 2 diabetes mellitus	0.000511	0.00202	CcSEcCtD
Rocuronium—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000511	0.00202	CcSEcCtD
Rocuronium—Nausea—Ramipril—type 2 diabetes mellitus	0.000482	0.00191	CcSEcCtD
Rocuronium—SLC22A1—Metabolism—HSD11B1—type 2 diabetes mellitus	6.12e-05	0.000459	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—UCP3—type 2 diabetes mellitus	6.12e-05	0.000459	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.11e-05	0.000458	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	6.01e-05	0.00045	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GCGR—type 2 diabetes mellitus	5.99e-05	0.000449	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.93e-05	0.000445	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	5.92e-05	0.000444	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	5.91e-05	0.000443	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	5.89e-05	0.000442	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	5.89e-05	0.000442	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CCR5—type 2 diabetes mellitus	5.87e-05	0.00044	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	5.86e-05	0.000439	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	5.84e-05	0.000438	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.81e-05	0.000436	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—MTR—type 2 diabetes mellitus	5.81e-05	0.000436	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PCK1—type 2 diabetes mellitus	5.76e-05	0.000432	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—C3—type 2 diabetes mellitus	5.73e-05	0.00043	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	5.72e-05	0.000429	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.7e-05	0.000427	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	5.69e-05	0.000426	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.67e-05	0.000425	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.66e-05	0.000424	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.66e-05	0.000424	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GCK—type 2 diabetes mellitus	5.66e-05	0.000424	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	5.66e-05	0.000424	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	5.64e-05	0.000423	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.63e-05	0.000422	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.53e-05	0.000414	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRK5—type 2 diabetes mellitus	5.51e-05	0.000413	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GIPR—type 2 diabetes mellitus	5.51e-05	0.000413	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CETP—type 2 diabetes mellitus	5.46e-05	0.00041	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	5.45e-05	0.000408	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—AGT—type 2 diabetes mellitus	5.45e-05	0.000408	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HK1—type 2 diabetes mellitus	5.39e-05	0.000404	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	5.32e-05	0.000399	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	5.29e-05	0.000396	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	5.28e-05	0.000395	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—LPA—type 2 diabetes mellitus	5.21e-05	0.00039	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—KCNJ11—type 2 diabetes mellitus	5.21e-05	0.00039	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HSD3B2—type 2 diabetes mellitus	5.21e-05	0.00039	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GCKR—type 2 diabetes mellitus	5.21e-05	0.00039	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	5.2e-05	0.00039	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	5.17e-05	0.000387	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	5.15e-05	0.000386	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.09e-05	0.000382	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PSMD6—type 2 diabetes mellitus	5.08e-05	0.000381	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SNAP25—type 2 diabetes mellitus	5.08e-05	0.000381	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SREBF1—type 2 diabetes mellitus	5.08e-05	0.000381	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MC4R—type 2 diabetes mellitus	5.04e-05	0.000378	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	5.04e-05	0.000377	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	5.01e-05	0.000376	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ALDOB—type 2 diabetes mellitus	4.99e-05	0.000374	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.99e-05	0.000374	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	4.95e-05	0.000371	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	4.95e-05	0.000371	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.94e-05	0.00037	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.87e-05	0.000365	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GIP—type 2 diabetes mellitus	4.85e-05	0.000364	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.84e-05	0.000363	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.84e-05	0.000362	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	4.8e-05	0.00036	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.76e-05	0.000357	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	4.67e-05	0.00035	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.65e-05	0.000348	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GLP1R—type 2 diabetes mellitus	4.64e-05	0.000348	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LEPR—type 2 diabetes mellitus	4.61e-05	0.000345	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP1A2—type 2 diabetes mellitus	4.59e-05	0.000344	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.59e-05	0.000344	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	4.59e-05	0.000344	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	4.57e-05	0.000343	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	4.57e-05	0.000342	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	4.55e-05	0.000341	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	4.51e-05	0.000338	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	4.5e-05	0.000337	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	4.49e-05	0.000336	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.48e-05	0.000336	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.47e-05	0.000335	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.46e-05	0.000334	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GCG—type 2 diabetes mellitus	4.4e-05	0.00033	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.4e-05	0.00033	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	4.4e-05	0.00033	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SLC2A2—type 2 diabetes mellitus	4.33e-05	0.000325	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TLE4—type 2 diabetes mellitus	4.28e-05	0.000321	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MTR—type 2 diabetes mellitus	4.24e-05	0.000318	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CPT1A—type 2 diabetes mellitus	4.24e-05	0.000318	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GCG—type 2 diabetes mellitus	4.16e-05	0.000312	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NAMPT—type 2 diabetes mellitus	4.16e-05	0.000312	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—LIPC—type 2 diabetes mellitus	4.14e-05	0.00031	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HBA1—type 2 diabetes mellitus	4.14e-05	0.00031	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GCK—type 2 diabetes mellitus	4.14e-05	0.00031	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	4.12e-05	0.000309	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP11A1—type 2 diabetes mellitus	4.11e-05	0.000308	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	4.1e-05	0.000307	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SLC9A1—type 2 diabetes mellitus	4.04e-05	0.000303	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CETP—type 2 diabetes mellitus	3.99e-05	0.000299	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	3.98e-05	0.000299	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	3.95e-05	0.000296	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	3.9e-05	0.000292	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.8e-05	0.000285	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.8e-05	0.000285	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.78e-05	0.000283	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CAT—type 2 diabetes mellitus	3.73e-05	0.000279	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PSMD6—type 2 diabetes mellitus	3.71e-05	0.000278	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SNAP25—type 2 diabetes mellitus	3.71e-05	0.000278	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SREBF1—type 2 diabetes mellitus	3.71e-05	0.000278	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	3.71e-05	0.000278	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	3.68e-05	0.000275	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	3.64e-05	0.000273	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	3.64e-05	0.000273	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CTGF—type 2 diabetes mellitus	3.64e-05	0.000273	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—APOB—type 2 diabetes mellitus	3.62e-05	0.000271	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HMGCR—type 2 diabetes mellitus	3.61e-05	0.000271	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	3.59e-05	0.000269	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RBP4—type 2 diabetes mellitus	3.55e-05	0.000266	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	3.55e-05	0.000266	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AVP—type 2 diabetes mellitus	3.54e-05	0.000265	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	3.54e-05	0.000265	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.54e-05	0.000265	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ADRA2A—type 2 diabetes mellitus	3.53e-05	0.000265	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	3.52e-05	0.000264	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.52e-05	0.000264	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.49e-05	0.000262	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—LPL—type 2 diabetes mellitus	3.46e-05	0.000259	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.39e-05	0.000254	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.38e-05	0.000254	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.37e-05	0.000253	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	3.37e-05	0.000252	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.35e-05	0.000251	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.35e-05	0.000251	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	3.32e-05	0.000249	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CD36—type 2 diabetes mellitus	3.28e-05	0.000246	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.27e-05	0.000245	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.24e-05	0.000243	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—C3—type 2 diabetes mellitus	3.24e-05	0.000243	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GCG—type 2 diabetes mellitus	3.22e-05	0.000241	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.22e-05	0.000241	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	3.2e-05	0.00024	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.16e-05	0.000237	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.14e-05	0.000236	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—INSR—type 2 diabetes mellitus	3.12e-05	0.000234	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.11e-05	0.000233	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.08e-05	0.000231	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.07e-05	0.00023	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.07e-05	0.00023	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.05e-05	0.000229	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.05e-05	0.000229	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.01e-05	0.000226	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AGT—type 2 diabetes mellitus	2.96e-05	0.000222	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—C3—type 2 diabetes mellitus	2.94e-05	0.000221	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	2.92e-05	0.000219	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.91e-05	0.000218	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—APOE—type 2 diabetes mellitus	2.9e-05	0.000217	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.86e-05	0.000215	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.84e-05	0.000213	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.84e-05	0.000213	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.84e-05	0.000213	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.8e-05	0.00021	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GNB3—type 2 diabetes mellitus	2.77e-05	0.000208	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.77e-05	0.000208	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.76e-05	0.000207	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HMOX1—type 2 diabetes mellitus	2.76e-05	0.000207	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.75e-05	0.000206	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.75e-05	0.000206	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CAT—type 2 diabetes mellitus	2.72e-05	0.000204	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.7e-05	0.000202	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.69e-05	0.000202	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.69e-05	0.000202	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.66e-05	0.000199	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—APOB—type 2 diabetes mellitus	2.64e-05	0.000198	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.58e-05	0.000194	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTM1—type 2 diabetes mellitus	2.57e-05	0.000193	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—LPL—type 2 diabetes mellitus	2.52e-05	0.000189	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.52e-05	0.000189	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.5e-05	0.000188	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.49e-05	0.000187	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—INS—type 2 diabetes mellitus	2.47e-05	0.000185	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ADCY5—type 2 diabetes mellitus	2.47e-05	0.000185	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GPX1—type 2 diabetes mellitus	2.46e-05	0.000185	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	2.46e-05	0.000184	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.46e-05	0.000184	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.42e-05	0.000181	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.41e-05	0.000181	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CD36—type 2 diabetes mellitus	2.4e-05	0.00018	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.37e-05	0.000178	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.3e-05	0.000173	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	2.27e-05	0.00017	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ALB—type 2 diabetes mellitus	2.27e-05	0.00017	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.26e-05	0.00017	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.26e-05	0.000169	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	2.23e-05	0.000167	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.17e-05	0.000163	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.17e-05	0.000163	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	2.16e-05	0.000162	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.14e-05	0.00016	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	2.12e-05	0.000159	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.12e-05	0.000159	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	2.12e-05	0.000159	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	2.09e-05	0.000157	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.09e-05	0.000157	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	2.09e-05	0.000157	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.08e-05	0.000156	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.07e-05	0.000155	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.05e-05	0.000154	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	2.02e-05	0.000152	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.01e-05	0.000151	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.99e-05	0.000149	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.98e-05	0.000149	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.93e-05	0.000145	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.89e-05	0.000142	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	1.84e-05	0.000138	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.81e-05	0.000136	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	1.81e-05	0.000135	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.78e-05	0.000133	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	1.74e-05	0.00013	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.66e-05	0.000124	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	1.66e-05	0.000124	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.65e-05	0.000124	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.65e-05	0.000124	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.62e-05	0.000122	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.62e-05	0.000121	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.62e-05	0.000121	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.6e-05	0.00012	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.58e-05	0.000119	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	1.58e-05	0.000119	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.53e-05	0.000114	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.45e-05	0.000109	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.44e-05	0.000108	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	1.38e-05	0.000104	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.36e-05	0.000102	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.34e-05	0.0001	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.34e-05	0.0001	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.33e-05	9.97e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.27e-05	9.52e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.21e-05	9.09e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.21e-05	9.09e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.14e-05	8.55e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.04e-05	7.79e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.03e-05	7.72e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.02e-05	7.67e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	9.98e-06	7.48e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.73e-06	7.29e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.62e-06	7.21e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.43e-06	7.07e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	8.97e-06	6.72e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.73e-06	6.55e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.02e-06	6.01e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.86e-06	5.89e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	7.29e-06	5.46e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.04e-06	4.53e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.57e-06	4.18e-05	CbGpPWpGaD
